UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response

The Lancet (British edition), 2009-09, Vol.374 (9693), p.921-933

2009

Volltextzugriff (PDF)

COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa

Current HIV/AIDS reports, 2022-02, Vol.19 (1), p.46-53

2022

Volltextzugriff (PDF)

Integration of Antiretroviral Therapy with Tuberculosis Treatment

The New England journal of medicine, 2011-10, Vol.365 (16), p.1492-1501

2011

Volltextzugriff (PDF)

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

The New England journal of medicine, 2010-02, Vol.362 (8), p.697-706

2010

Volltextzugriff (PDF)

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

Science (American Association for the Advancement of Science), 2010-09, Vol.329 (5996), p.1168-1174

2010

Volltextzugriff (PDF)

Sexually transmitted infections in pregnancy and adverse pregnancy outcomes: A retrospective cohort study

International journal of gynecology and obstetrics, 2024-07, Vol.166 (1), p.62-70

2024

Volltextzugriff (PDF)

Innate Immune Activation Enhances HIV Acquisition in Women, Diminishing the Effectiveness of Tenofovir Microbicide Gel

The Journal of infectious diseases, 2012-10, Vol.206 (7), p.993-1001

2012

Volltextzugriff (PDF)

Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy

The Journal of infectious diseases, 2014-02, Vol.209 (4), p.500-509

2014

Volltextzugriff (PDF)

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape

Nature medicine, 2012-11, Vol.18 (11), p.1688-1692

2012

Volltextzugriff (PDF)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

The Lancet (British edition), 2021-12, Vol.398 (10317), p.2126-2128

2021

Volltextzugriff (PDF)

Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression

Scientific reports, 2022-02, Vol.12 (1), p.2437-2437, Article 2437

2022

Volltextzugriff (PDF)

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection

The New England journal of medicine, 2015-08, Vol.373 (6), p.530-539

2015

Volltextzugriff (PDF)

Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study

Sexually transmitted infections, 2014-12, Vol.90 (8), p.580-587

2014

Volltextzugriff (PDF)

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection

The New England journal of medicine, 2015-08, Vol.373 (6), p.530-539

2015

Volltextzugriff (PDF)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition

Nature communications, 2019-11, Vol.10 (1), p.5227-12, Article 5227

2019

Volltextzugriff (PDF)

Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision

PloS one, 2022-01, Vol.17 (1), p.e0262043-e0262043

2022

Volltextzugriff (PDF)

Identification of adolescent girls and young women for targeted HIV prevention: a new risk scoring tool in KwaZulu Natal, South Africa

Scientific reports, 2020-08, Vol.10 (1), p.13017-13017, Article 13017

2020

Volltextzugriff (PDF)

HIV-No time for complacency

Science (American Association for the Advancement of Science), 2018-06, Vol.360 (6394), p.1153-1153

2018

Volltextzugriff (PDF)

Preventing HIV Infection in Women: A global Health Imperative

Clinical infectious diseases, 2010-05, Vol.50 (Supplement-3), p.S122-S129

2010

Volltextzugriff (PDF)

Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa

PloS one, 2019-02, Vol.14 (2), p.e0212343-e0212343

2019

Volltextzugriff (PDF)

HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention

PLoS medicine, 2022-09, Vol.19 (9), p.e1004102-e1004102

2022

Volltextzugriff (PDF)

Achieving the health Millennium Development Goals for South Africa: challenges and priorities

The Lancet (British edition), 2009-09, Vol.374 (9694), p.1023-1031

2009

Volltextzugriff (PDF)

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women

BMJ open, 2022-01, Vol.12 (1), p.e052880-e052880

2022

Volltextzugriff (PDF)

Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis

Frontiers in immunology, 2021-09, Vol.12, p.730986-730986

2021

Volltextzugriff (PDF)

COVID-19 and global equity for health: The good, the bad, and the wicked

PLoS medicine, 2021-10, Vol.18 (10), p.e1003797-e1003797

2021

Volltextzugriff (PDF)

1 – 25 von 385

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(322)
Mit Volltextzugriff
(308)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(380)
Portugiesisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(242)
Humans
(219)
Life Sciences & Biomedicine
(212)
Hiv
(189)
Female
(168)
Human Immunodeficiency Virus
(159)
Infectious Diseases
(131)
Hiv Infections - Prevention & Control
(105)
Adult
(97)
Aids
(97)
Immunology
(84)
Acquired Immune Deficiency Syndrome
(80)
Adolescent
(68)
South Africa
(68)
Young Adult
(66)
Hiv Infections - Epidemiology
(65)
Public Health
(60)
Male
(58)
Medicine, General & Internal
(57)
Prevention
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response

COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa

Integration of Antiretroviral Therapy with Tuberculosis Treatment

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

Sexually transmitted infections in pregnancy and adverse pregnancy outcomes: A retrospective cohort study

Innate Immune Activation Enhances HIV Acquisition in Women, Diminishing the Effectiveness of Tenofovir Microbicide Gel

Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection

Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition

Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision

Identification of adolescent girls and young women for targeted HIV prevention: a new risk scoring tool in KwaZulu Natal, South Africa

HIV-No time for complacency

Preventing HIV Infection in Women: A global Health Imperative

Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa

HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention

Achieving the health Millennium Development Goals for South Africa: challenges and priorities

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women

Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis

COVID-19 and global equity for health: The good, the bad, and the wicked

Suchergebnisse filtern